GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biomind Labs Inc (FRA:3XI) » Definitions » Price-to-Owner-Earnings

Biomind Labs (FRA:3XI) Price-to-Owner-Earnings : (As of May. 23, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Biomind Labs Price-to-Owner-Earnings?

As of today (2025-05-23), Biomind Labs's share price is €0.246. Biomind Labs does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Biomind Labs's Price-to-Owner-Earnings or its related term are showing as below:


FRA:3XI's Price-to-Owner-Earnings is not ranked *
in the Biotechnology industry.
Industry Median: 28.53
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2025-05-23), Biomind Labs's share price is €0.246. Biomind Labs's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was €-0.01. Therefore, Biomind Labs's PE Ratio (TTM) for today is At Loss.

As of today (2025-05-23), Biomind Labs's share price is €0.246. Biomind Labs's EPS without NRI for the trailing twelve months (TTM) ended in was €-0.01. Therefore, Biomind Labs's PE Ratio without NRI for today is At Loss.


Biomind Labs Price-to-Owner-Earnings Historical Data

The historical data trend for Biomind Labs's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomind Labs Price-to-Owner-Earnings Chart

Biomind Labs Annual Data
Trend Dec21 Dec22 Dec23
Price-to-Owner-Earnings
- - -

Biomind Labs Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Biomind Labs's Price-to-Owner-Earnings

For the Biotechnology subindustry, Biomind Labs's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biomind Labs's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biomind Labs's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Biomind Labs's Price-to-Owner-Earnings falls into.


;
;

Biomind Labs Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Biomind Labs's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=0.246/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biomind Labs  (FRA:3XI) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Biomind Labs Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Biomind Labs's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Biomind Labs Business Description

Traded in Other Exchanges
Address
Camino Saravia s/n, Pando Science and Technology Park, Pando Canelones, Canelones, URY, CP 91.000
Biomind Labs Inc is a biotech Research and Development company aimed at transforming biomedical sciences knowledge from natural psychotropic plants into novel pharmaceutical drugs and nanotech delivery systems for a variety of psychiatric and neurological conditions. Biomind is developing pharmaceutical sole and combined formulations of the main natural psychedelic molecules with the aim of identifying novel pharmaceutical compounds for treating a wide range of therapeutic indications.

Biomind Labs Headlines

No Headlines